Publication | Closed Access
Pindolol Augmentation of Selective Serotonin Reuptake Inhibitors: PET Evidence That the Dose Used in Clinical Trials Is Too Low
77
Citations
6
References
2001
Year
The dose of pindolol used in clinical trials is suboptimal and may explain the inconsistent results. Therefore, a thorough test of pindolol's efficacy will necessitate doses higher than those used in present clinical trials.
| Year | Citations | |
|---|---|---|
1996 | 181 | |
1999 | 155 | |
1998 | 126 | |
2000 | 76 | |
2000 | 50 | |
2000 | 22 |
Page 1
Page 1